Home Cart 0 Sign in  

[ CAS No. 857531-00-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 857531-00-1
Chemical Structure| 857531-00-1
Structure of 857531-00-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 857531-00-1 ]

Related Doc. of [ 857531-00-1 ]

Alternatived Products of [ 857531-00-1 ]

Product Details of [ 857531-00-1 ]

CAS No. :857531-00-1 MDL No. :MFCD18384971
Formula : C20H20ClN3 Boiling Point : -
Linear Structure Formula :- InChI Key :LZMOSYUFVYJEPY-UHFFFAOYSA-N
M.W : 337.85 Pubchem ID :11175137
Synonyms :

Calculated chemistry of [ 857531-00-1 ]

Physicochemical Properties

Num. heavy atoms : 24
Num. arom. heavy atoms : 17
Fraction Csp3 : 0.25
Num. rotatable bonds : 3
Num. H-bond acceptors : 2.0
Num. H-bond donors : 2.0
Molar Refractivity : 102.2
TPSA : 40.71 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -5.34 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.53
Log Po/w (XLOGP3) : 4.25
Log Po/w (WLOGP) : 4.02
Log Po/w (MLOGP) : 3.69
Log Po/w (SILICOS-IT) : 5.36
Consensus Log Po/w : 3.97

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.94
Solubility : 0.00389 mg/ml ; 0.0000115 mol/l
Class : Moderately soluble
Log S (Ali) : -4.82
Solubility : 0.00516 mg/ml ; 0.0000153 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -8.28
Solubility : 0.00000176 mg/ml ; 0.0000000052 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.36

Safety of [ 857531-00-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 857531-00-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 857531-00-1 ]

[ 857531-00-1 ] Synthesis Path-Downstream   1~4

  • 1
  • [ 857531-01-2 ]
  • [ 269410-08-4 ]
  • [ 857531-00-1 ]
YieldReaction ConditionsOperation in experiment
33% With potassium phosphate In various solvent(s) at 135℃; for 30h; microwave irradiation;
14.B 14B. 14B. 4-(4-Chloro-phenyl)-4-[4(1H-pyrazol-4-yl)-phenyl]-piperidine 4-(4-Bromo-phenyl)-4-(4-chloro-phenyl)-piperidine was reacted with 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole following the procedure set out in Example 1 to give the title compound. LC/MS: (PS-A3) Rt 7.22 [M+H]+ 338.08. 1H NMR (Me-d3-OD) δ 2.64-2.74 (4H, m), 3.22-3.25 (4H, m), 7.33-7.45 (6H, m), 7.65 (2H, d), 8.37 (2H, s).
  • 2
  • [ CAS Unavailable ]
  • [ 857531-00-1 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 1: 92 percent / AlCl3 / 2 h / 0 °C 2: 33 percent / K3PO4 / bis(tri-t-butylphosphine)palladium(0) / various solvent(s) / 30 h / 135 °C / microwave irradiation
  • 3
  • [ 57988-58-6 ]
  • [ 857531-00-1 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 1: 92 percent / AlCl3 / 2 h / 0 °C 2: 33 percent / K3PO4 / bis(tri-t-butylphosphine)palladium(0) / various solvent(s) / 30 h / 135 °C / microwave irradiation
Same Skeleton Products
Historical Records